{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-036400","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2023-10-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.417580+00:00","generated_at":"2026-06-10T03:47:24.854322+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Oragenics expands board from 5 to 7, appoints Cassidy and Gandolfo as directors","bullets":["Board size increased from 5 to 7; Bruce Cassidy and John Gandolfo appointed as directors.","Cassidy brings leadership experience in entertainment/media; Gandolfo is CFO of Eyenovia with life sciences CFO background.","Each granted immediate vesting option to purchase 5,102 shares at fair market value.","Both agreed to stand for re-election at the next annual meeting of shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-036400","json":"https://secwatch.observer/filing/0001493152-23-036400.json","markdown":"https://secwatch.observer/filing/0001493152-23-036400.md","text":"https://secwatch.observer/filing/0001493152-23-036400.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223036400/0001493152-23-036400-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223036400/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T03:47:24.854322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"004d10ae99","claim":"Bruce Cassidy was appointed as Director at ORAGENICS INC.","evidence_excerpt":"Following the increase in the size of the Company’s board of directors, the Board of Directors appointed Mr. Bruce Cassidy and Mr. John Gandolfo to the Company’s board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223036400/0001493152-23-036400-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"348ea7008f","claim":"John Gandolfo was appointed as Director at ORAGENICS INC.","evidence_excerpt":"Following the increase in the size of the Company’s board of directors, the Board of Directors appointed Mr. Bruce Cassidy and Mr. John Gandolfo to the Company’s board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223036400/0001493152-23-036400-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}